We have now demonstrated that in the wild-type setting, unlike their CD4 counterparts, CNS-CD8 not only fail to transfer or exacerbate demyelinating disease, but are unexpectedly protective against EAE (7). This evidence concerns the gene CD8A and demyelinating disease.